Selank 5mg

CLASSIFICATION Anxiolytic Peptide
ACNE No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Beligas
WAREHOUSE International Warehouse 3
SUBSTANCE Selank

In the rapidly evolving world of biotechnology, innovative biologically active substances are gaining attention, notably "cognitive enhancers" or "nootropics." One standout in this field is Selank, previously known as ?TP-7.? This synthetic peptide?a small, artificially engineered protein?is renowned for its potential benefits.

Marketed as an "anti-anxiety" solution, Selank is believed to enhance cognitive function and increase energy levels without the risk of significant side effects or addiction.

Developed at the Institute of Molecular Genetics (Russian Academy of Sciences) in collaboration with the V.V. Zakusov Research Institute of Pharmacology, Selank is notably smaller than most natural proteins. It combines the sequence of a peptide called tuftsin, which is part of IgG antibodies, with an additional sequence that boosts its stability.

Research indicates that both tuftsin and Selank can reduce anxiety and elevate serotonin levels in animal models, with Selank showing slightly superior efficacy.

While Selank has been approved in Russia for treating generalized anxiety disorder (GAD) and as a nootropic, it remains unapproved by the FDA for medical use in the United States. However, it is widely available in many countries as a "nutritional supplement."

Though the exact mechanisms of Selank aren't fully understood, it is thought to stabilize enkephalins in the bloodstream?natural peptides that help regulate stress responses. Some studies have suggested that Selank interacts with GABA receptors, which are known to induce calming effects, resulting in decreased brain activity.

There are also indications that Selank may elevate levels of brain-derived neurotrophic factor (BDNF), essential for brain health, learning, and memory. This could explain some of Selank's purported cognitive advantages.

Additionally, Selank has been observed to influence neurotransmitter levels such as norepinephrine, dopamine, and serotonin, which are crucial for motivation, focus, and pleasure. However, findings vary across studies, highlighting the need for further investigation into its specific effects.

In a preliminary clinical trial with 62 participants, Selank demonstrated a reduction in anxiety symptoms, particularly among those with anxiety disorders. Another study involving 60 patients with anxiety and phobias reported similar positive outcomes, with effects lasting up to a week post-treatment.

In a different trial involving 70 anxiety patients, Selank was shown to enhance the effects of phenazepam (an anti-anxiety medication) while minimizing side effects like drowsiness and memory loss. Animal studies have corroborated these findings, indicating that Selank can reduce anxiety in mice, particularly in those with higher baseline anxiety levels.

While the evidence is encouraging, further research is necessary to confirm Selank's effectiveness and safety in humans. Consultation with a healthcare professional is advisable for those considering Selank as an alternative treatment for anxiety.

In a 30-day study, Selank was linked to the stabilization of memory traces in rats, though the measurement methods were unclear. Another animal study suggested potential memory preservation in monkeys, but reliable human studies are still lacking.

Research indicates that Selank may restore normal brain activity in rats with toxin-induced brain damage.

Selank has been associated with reduced depressive symptoms in mice, particularly at lower doses.

Preliminary studies have shown that Selank injections can boost antioxidant levels in the livers of stressed mice.

In sedated cats, Selank was found to temporarily lower blood pressure and increase brain blood flow. However, these effects appear to be short-lived and require further exploration for medical relevance.

Selank may help alleviate anxiety during alcohol withdrawal, as evidenced by a study where rats showed reduced anxiety following withdrawal when treated with Selank.

In studies involving rats on a high-fat diet, those treated with Selank gained significantly less weight and exhibited notable reductions in cholesterol and blood glucose levels.

Early findings in mice indicate that Selank may slow tumor growth in breast cancer models, but extensive research is necessary to establish its safety and efficacy in cancer treatment.

Selank treatment has been shown to elevate inflammatory response genes in mouse spleens, potentially offering some inflammation-related protection.

Selank may reduce stomach ulcer size in animal models, potentially by improving lymphatic flow to the stomach, but human studies are essential for further validation.

Selank has been reported to enhance IL-6 levels in blood cells from depressive patients and stimulate interferon release, which may have antiviral properties. However, one study did not find antiviral benefits in virus-infected mice, suggesting that more research is needed.